Late-Onset Retinoblastoma: Clinical and Genetic Features in Children Presenting Over 5 Years Old

William I Evans1, Barrett N Thompson2, Benjamin A King1

  • 1Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee, Memphis, Tennessee; Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee.

Ophthalmology. Retina
|July 27, 2025
PubMed

Insights

Late-onset retinoblastoma in older children is often misdiagnosed. Genetic predisposition, including RB1 mutations, is more common than expected in these unilateral cases, impacting prognosis.

Area of Science:

  • Ophthalmology
  • Pediatric Oncology
  • Clinical Genetics

Background:

  • Retinoblastoma is typically diagnosed in infants and young children.
  • Late-onset retinoblastoma (diagnosed at age ≥5 years) is rare but presents unique clinical and genetic challenges.
  • Understanding these cases is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To define the clinical characteristics of retinoblastoma in children diagnosed at age five or older.
  • To investigate the genetic factors associated with late-onset retinoblastoma.
  • To identify potential reasons for delayed diagnosis in this patient group.

Main Methods:

  • Retrospective chart review of children treated for retinoblastoma at a single institution (1999-2022).
  • Analysis of demographics, genetic testing results, laterality, presenting symptoms, and prior misdiagnoses.
  • Evaluation of tumor classification, treatments, outcomes, and RB1 gene status (germline mutations and promoter hypermethylation).

Main Results:

  • 25 of 529 retinoblastoma patients (4.7%) were diagnosed at age ≥5 years (median age 6.0 years).
  • Most presented with unilateral disease (96%), and 36% were initially misdiagnosed.
  • Pathogenic germline RB1 mutations were found in 25% of tested patients, and RB1 promoter hypermethylation in 2 of 6 tumors.

Conclusions:

  • Children diagnosed with retinoblastoma at an older age are frequently misdiagnosed prior to presentation.
  • Germline genetic predisposition is more common in late-onset unilateral retinoblastoma than previously thought.
  • These findings have significant implications for improving diagnostic accuracy, treatment strategies, and patient prognosis.
Abstract

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K